Text Size

Hypnosis as a Treatment of Chronic Widespread Pain in General Practice. A Pilot Study.

This study has been completed.
Sponsor:
Information provided by:
University of Oslo
ClinicalTrials.gov Identifier:
NCT00521807
First received: August 27, 2007
Last updated: October 17, 2008
Last verified: August 2007
History of Changes
  Purpose

Objective: The study was performed to evaluate the effect of a standardized hypnosis treatment used in general practice for patients with chronic widespread pain (CWP).

Design: A randomized control group-controlled study. Setting and subjects: 16 patients were randomized into a treatment group or a control group, each constituting eight patients. Seven patients in the treatment group completed the schedule. After the control period, five of the patients in the control group also received treatment, making a total of 12 patients having completed the treatment sessions.

Intervention: The intervention group went through a standardized hypnosis treatment with ten consecutive therapeutic sessions once a week, each lasting for about 30 minutes, focusing on ego-strengthening, relaxation, releasing muscular tension and increasing self-efficacy.

Main outcome measures: A questionnaire was developed in order to calibrate the symptoms before and after the 10 weeks period, and the results were interpolated into a scale from 0 to 100, increasing numbers representing increasing suffering.


Condition Intervention
Chronic Widespread Pain
 Procedure: Hypnosis

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Further study details as provided by University of Oslo:

Enrollment: 18
Study Start Date: March 2001
Study Completion Date: May 2005
Arms Assigned Interventions
No Intervention: A 1
Experimental: A 2
Treatment group
 Procedure: Hypnosis
a standardized hypnosis treatment with ten consecutive therapeutic sessions once a week,

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Chronic widespread pain for at least three months and at most five years.

Exclusion Criteria:

  • Patients having primarily other organic diseases or serious psychiatric disorders were excluded.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00521807

Locations
Norway
1) Institute of General Practice and Community Medicine, University of Oslo
Oslo, Norway, 0318
Sponsors and Collaborators
University of Oslo
Investigators
Principal Investigator: Jan R Grondahl, Dr The Institute of General Practice and Community Medicine, University of Oslo, Norway.
  More Information

No publications provided by University of Oslo

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

ClinicalTrials.gov Identifier: NCT00521807     History of Changes
Other Study ID Numbers: 26035831907
Study First Received: August 27, 2007
Last Updated: October 17, 2008
Health Authority: Norway: The Committee for Medical Research Ethics.

Keywords provided by University of Oslo:
Hypnosis,
Chronic widespread pain,
CWP,
General Practice

ClinicalTrials.gov processed this record on May 19, 2013